Language
Products

Products

All categories

EasyNAT® Novel-Coronavirus (2019-nCoV) Real-Time Molecular Diagnostic System

  • Categories:COVID-19
  • Time of issue:2020-08-13 00:00:00
  • Views:0
Description:
Description:
Information

news

 

Ustar EasyNAT ® Novel-Coronavirus (2019-nCoV) Real-Time Molecular Diagnostic System integrates with the process of nucleic acid extraction, amplification and detection in one equipment that only need one step operation to realize "sample in, result out" in 55 minutes.

 

【Core Technologies】

● Cross Priming Isothermal Amplification Technology (CPA)

● Reagent Vitrification Technology

 

【Workflow】

 

COVID-19

 

【Advantages】

● Safe: fully closed detection process, effectively prevent cross contamination.

● Proven Cartridge Technology

● Fast: “sample in, result out” in 55 minutes.

● Accurate: sensitivity of 98%, specificity of 95.4%.

● Simple: pre-loaded reagents without special personnel or professional laboratories.

● Automatic: integrated process of nucleic acid extraction, amplification and detection in one equipment.

● Normal temperature transportation: exclusive reagent vitrification technology that could store and transport reagents at normal temperature.

Contact us

Ustar Biotechnologies (Hangzhou) Ltd.  (Headquarters)
Add: 8/F, New Century Tower, 3766 Nanhuan Road, Binjiang Dist, Hangzhou, Zhejiang, P.R.China
Zip: 310053

Email: sales@bioustar.com    service@bioutsar.com
Tel: +86-571-88939368 (Switchboard)
       +86-571-88939358 (Sales) 
       +86-400-870-7025 (Service)

Copyright Ustar Biotechnologies 2018. All rights reserved   浙ICP备20029265号       Powered by www.300.cn

Ustar